Connecticut Skin Institute, M.D.

Connecticut Skin Institute, M. D. specializes in dermatological and skin rejuvenation services, offering advanced treatments tailored to various skin concerns, including both medical and cosmetic dermatology. Founded in 2012 and headquartered in Stamford, Connecticut, Connecticut Skin Institute provides specialized dermatological care.

The institute was established by Dr. Omar Ibrahimi, who has a background in dermatology and has previously worked in various esteemed medical settings. There are no publicly available details on any changes in business operations or subsidiaries. Connecticut Skin Institute (CSI) is a leading provider of dermatological and skin rejuvenation services, focusing on a wide range of treatments tailored to address various skin concerns.

Their core offerings include medical dermatology, cosmetic procedures, and surgical dermatology, utilizing advanced technology such as laser treatments, chemical peels, and injectable therapies. Notable services include Kybella for double chin fat reduction, Fraxel for skin resurfacing, and CoolSculpting for non-invasive body contouring. These services cater to a diverse clientele, including adults seeking aesthetic improvements and patients requiring medical dermatology interventions. CSI primarily serves the Connecticut region, though its reputation attracts patients from broader markets, including surrounding states seeking specialized skin care solutions.

Connecticut Skin Institute generates revenue through direct-to-consumer transactions for its dermatological and cosmetic services. Patients typically schedule consultations and treatments, either through self-referral or via healthcare provider recommendations. The practice operates on a fee-for-service model, where clients pay for individual treatments such as laser hair removal, tattoo removal, and other cosmetic interventions. Pricing structures for these services are established based on the type and complexity of the treatment, with some premium services, such as Mohs surgery for skin cancer, reflecting higher costs due to their specialized nature.

This transactional framework ensures a consistent revenue stream while maintaining high standards of care and personalized service for its patient base.